Logo-jrip
Submitted: 06 May 2022
Accepted: 20 Aug 2022
ePublished: 28 Aug 2022
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Renal Inj Prev. 2023;12(1): e32060.
doi: 10.34172/jrip.2022.32060
  Abstract View: 217
  PDF Download: 51

Review

State of the gut microbiota in oxalate nephrolithiasis

Nikolay V. Sturov ORCID logo, Sergey V. Popov ORCID logo, Zakhar A. Ivanov* ORCID logo, Ekaterina I. Rusanova ORCID logo, Georgy N. Kobylyanu ORCID logo

1 Department of General Practice, Medicine Institute, RUDN University, Moscow, Russia
*Corresponding Author: Corresponding author: Zakhar A. Ivanov, Email: 1042210260@pfur.ru,, Email: zakhar.ivanov@list.ru

Abstract

The gut microbiota (GM) is currently considered as a pathogenic factor in a number of diseases. It is known that some gastrointestinal diseases cause a high risk of developing urolithiasis. The study gives modern data demonstrating the influence of the GM, in particular Oxalobacter formigenes, on the formation of oxalate kidney stones. The relationship between the presence of inflammatory bowel diseases and the use of antimicrobial drugs with oxalate homeostasis was demonstrated, methods for correcting the GM in patients with urolithiasis, including the use of probiotics and diet therapy, were analyzed. The studies presented in the article demonstrate that the correction of the GM can be considered as a therapeutic goal and be an actual component of the complex treatment and metaphylaxis of nephrolithiasis.

Implication for health policy/practice/research/medical education:

Urolithiasis is a common disease that affects patients of all ages and significantly reduces the quality of life. With technological advancements and growing expertise, nephrolithiasis can be diagnosed more easily than before. A better understanding of the relationship of this disease with the intestinal microbiota discussed in this study will lead to improved metaphylaxis and proper treatment of nephrolithiasis. This, in turn, will reduce the prevalence of kidney stones.

Please cite this paper as: Sturov NV, Popov SV, Ivanov ZA, Rusanova EI, Kobylyanu GN. State of the gut microbiota in oxalate nephrolithiasis. J Renal Inj Prev. 2023; 12(1): e32060. doi: 10.34172/jrip.2022.32060.

First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 218

Your browser does not support the canvas element.


PDF Download: 51

Your browser does not support the canvas element.